Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Type (2014-2025) 1.4.2 Pharmacogenomic Diagnosis 1.4.3 Liquid Biopsy 1.4.4 Other 1.5 Market by Application 1.5.1 Global Molecular Diagnostics Cancer Market Share by Application (2019-2025) 1.5.2 Respiratory Cancer 1.5.3 Cancer of Digestive System 1.5.4 Cancer of Urinary System 1.5.5 Cancer of Circulatory System 1.5.6 Motor System Cancer 1.5.7 Reproductive System Cancer 1.5.8 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Molecular Diagnostics Cancer Market Size 2.2 Molecular Diagnostics Cancer Growth Trends by Regions 2.2.1 Molecular Diagnostics Cancer Market Size by Regions (2019-2025) 2.2.2 Molecular Diagnostics Cancer Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Molecular Diagnostics Cancer Market Size by by Players 3.1.1 Global Molecular Diagnostics Cancer Revenue by by Players (2014-2019) 3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by by Players (2014-2019) 3.1.3 Global Molecular Diagnostics Cancer Market Concentration Ratio (CR5 and HHI) 3.2 Molecular Diagnostics Cancer Key Players Head office and Area Served 3.3 Key Players Molecular Diagnostics Cancer Product/Solution/Service 3.4 Date of Enter into Molecular Diagnostics Cancer Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Molecular Diagnostics Cancer Market Size by Type (2014-2019) 4.2 Global Molecular Diagnostics Cancer Market Size by Application (2014-2019) 5 North America 5.1 North America Molecular Diagnostics Cancer Market Size (2014-2019) 5.2 Molecular Diagnostics Cancer Key Players in North America 5.3 North America Molecular Diagnostics Cancer Market Size by Type 5.4 North America Molecular Diagnostics Cancer Market Size by Application 6 Europe 6.1 Europe Molecular Diagnostics Cancer Market Size (2014-2019) 6.2 Molecular Diagnostics Cancer Key Players in Europe 6.3 Europe Molecular Diagnostics Cancer Market Size by Type 6.4 Europe Molecular Diagnostics Cancer Market Size by Application 7 China 7.1 China Molecular Diagnostics Cancer Market Size (2014-2019) 7.2 Molecular Diagnostics Cancer Key Players in China 7.3 China Molecular Diagnostics Cancer Market Size by Type 7.4 China Molecular Diagnostics Cancer Market Size by Application 8 Japan 8.1 Japan Molecular Diagnostics Cancer Market Size (2014-2019) 8.2 Molecular Diagnostics Cancer Key Players in Japan 8.3 Japan Molecular Diagnostics Cancer Market Size by Type 8.4 Japan Molecular Diagnostics Cancer Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Molecular Diagnostics Cancer Market Size (2014-2019) 9.2 Molecular Diagnostics Cancer Key Players in Southeast Asia 9.3 Southeast Asia Molecular Diagnostics Cancer Market Size by Type 9.4 Southeast Asia Molecular Diagnostics Cancer Market Size by Application 10 India 10.1 India Molecular Diagnostics Cancer Market Size (2014-2019) 10.2 Molecular Diagnostics Cancer Key Players in India 10.3 India Molecular Diagnostics Cancer Market Size by Type 10.4 India Molecular Diagnostics Cancer Market Size by Application 11 Central & South America 11.1 Central & South America Molecular Diagnostics Cancer Market Size (2014-2019) 11.2 Molecular Diagnostics Cancer Key Players in Central & South America 11.3 Central & South America Molecular Diagnostics Cancer Market Size by Type 11.4 Central & South America Molecular Diagnostics Cancer Market Size by Application 12 International Players Profiles 12.1 Roche 12.1.1 Roche Company Details 12.1.2 Company Description and Business Overview 12.1.3 Molecular Diagnostics Cancer Introduction 12.1.4 Roche Revenue in Molecular Diagnostics Cancer Business (2014-2019)) 12.1.5 Roche Recent Development 12.2 Danaher 12.2.1 Danaher Company Details 12.2.2 Company Description and Business Overview 12.2.3 Molecular Diagnostics Cancer Introduction 12.2.4 Danaher Revenue in Molecular Diagnostics Cancer Business (2014-2019) 12.2.5 Danaher Recent Development 12.3 Siemens 12.3.1 Siemens Company Details 12.3.2 Company Description and Business Overview 12.3.3 Molecular Diagnostics Cancer Introduction 12.3.4 Siemens Revenue in Molecular Diagnostics Cancer Business (2014-2019) 12.3.5 Siemens Recent Development 12.4 Abbott Laboratories 12.4.1 Abbott Laboratories Company Details 12.4.2 Company Description and Business Overview 12.4.3 Molecular Diagnostics Cancer Introduction 12.4.4 Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2014-2019) 12.4.5 Abbott Laboratories Recent Development 12.5 ICON Plc 12.5.1 ICON Plc Company Details 12.5.2 Company Description and Business Overview 12.5.3 Molecular Diagnostics Cancer Introduction 12.5.4 ICON Plc Revenue in Molecular Diagnostics Cancer Business (2014-2019) 12.5.5 ICON Plc Recent Development 12.6 AstraZeneca 12.6.1 AstraZeneca Company Details 12.6.2 Company Description and Business Overview 12.6.3 Molecular Diagnostics Cancer Introduction 12.6.4 AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2014-2019) 12.6.5 AstraZeneca Recent Development 12.7 MDxHealth 12.7.1 MDxHealth Company Details 12.7.2 Company Description and Business Overview 12.7.3 Molecular Diagnostics Cancer Introduction 12.7.4 MDxHealth Revenue in Molecular Diagnostics Cancer Business (2014-2019) 12.7.5 MDxHealth Recent Development 12.8 Invitae 12.8.1 Invitae Company Details 12.8.2 Company Description and Business Overview 12.8.3 Molecular Diagnostics Cancer Introduction 12.8.4 Invitae Revenue in Molecular Diagnostics Cancer Business (2014-2019) 12.8.5 Invitae Recent Development 12.9 PlexBio 12.9.1 PlexBio Company Details 12.9.2 Company Description and Business Overview 12.9.3 Molecular Diagnostics Cancer Introduction 12.9.4 PlexBio Revenue in Molecular Diagnostics Cancer Business (2014-2019) 12.9.5 PlexBio Recent Development 12.10 Thermo Fisher Scientific 12.10.1 Thermo Fisher Scientific Company Details 12.10.2 Company Description and Business Overview 12.10.3 Molecular Diagnostics Cancer Introduction 12.10.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2014-2019) 12.10.5 Thermo Fisher Scientific Recent Development 12.11 Guardant Health 12.12 Biocartis 12.13 Bio-Techne 12.14 Merck 12.15 Foundation Medicine 12.16 10X Genomics 12.17 Biodesix 12.18 CytoTrack 12.19 GenomOncology 12.20 Luminex 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Product (2019-2025) 13.2 Market Size Forecast by Application (2019-2025) 13.3 Market Size Forecast by Regions 13.4 North America 13.5 Europe 13.6 China 13.7 Japan 13.8 Southeast Asia 13.9 India 13.10 Central & South America 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Molecular Diagnostics Cancer Key Market Segments Table Key Players Molecular Diagnostics Cancer Covered Table Global Molecular Diagnostics Cancer Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer Pharmacogenomic Diagnosis Figures Table Key Players of Pharmacogenomic Diagnosis Figuer Liquid Biopsy Figures Table Key Players of Liquid Biopsy Figuer Other Figures Table Key Players of Other Table Global Molecular Diagnostics Cancer Market Size Growth by Application 2019-2025 (Million US$) Figure Global Molecular Diagnostics Cancer Market Share by Application in 2018 & 2025 Figure Respiratory Cancer Case Studies Figure Cancer of Digestive System Case Studies Figure Cancer of Urinary System Case Studies Figure Cancer of Circulatory System Case Studies Figure Motor System Cancer Case Studies Figure Reproductive System Cancer Case Studies Figure Other Case Studies Figure Molecular Diagnostics Cancer Report Years Considered Figure Global Molecular Diagnostics Cancer Market Size and Growth Rate 2014-2025 (Million US$) Table Global Molecular Diagnostics Cancer Market Size by Regions 2019-2025 (Million US$) Table Global Molecular Diagnostics Cancer Market Size by Regions 2019-2025 (Million US$) Table Global Molecular Diagnostics Cancer Market Share by Regions 2014-2019 Figure Global Molecular Diagnostics Cancer Market Share by Regions 2014-2019 Figure Global Molecular Diagnostics Cancer Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Molecular Diagnostics Cancer Revenue by by Players (2014-2019) (Million US$) Table Global Molecular Diagnostics Cancer Market Share by by Players (2014-2019) Figure Global Molecular Diagnostics Cancer Market Share by by Players in 2018 Table Global Molecular Diagnostics Cancer by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Molecular Diagnostics Cancer Product/Solution/Service Table Date of Enter into Molecular Diagnostics Cancer Market Table Mergers & Acquisitions, Expansion Plans Table Global Molecular Diagnostics Cancer Market Size by Type (2014-2019) (Million US$) Table Global Molecular Diagnostics Cancer Market Size Share by Type (2014-2019) Figure Global Molecular Diagnostics Cancer Market Size Market Share by Type (2014-2019) Table Global Molecular Diagnostics Cancer Market Size by Application (2014-2019) (Million US$) Table Global Molecular Diagnostics Cancer Market Size Share by Application (2014-2019) Figure Global Molecular Diagnostics Cancer Market Size Market Share by Application (2014-2019) Figure Global Molecular Diagnostics Cancer Revenue Market Share by Application in 2018 Figure North America Molecular Diagnostics Cancer Market Size 2014-2019 (Million US$) Table North America Key Players Molecular Diagnostics Cancer Revenue (2018-2019) (Million US$) Table North America Key Players Molecular Diagnostics Cancer Market Share (2018-2019) Table North America Molecular Diagnostics Cancer Market Size by Type 2014-2019 (Million US$) Table North America Molecular Diagnostics Cancer Market Share by Type 2014-2019 Table North America Molecular Diagnostics Cancer Market Size by Application 2014-2019 (Million US$) Table North America Molecular Diagnostics Cancer Market Share by Application 2014-2019 Figure Europe Molecular Diagnostics Cancer Market Size 2014-2019 (Million US$) Table Europe Key Players Molecular Diagnostics Cancer Revenue (2018-2019) (Million US$) Table Europe Key Players Molecular Diagnostics Cancer Market Share (2018-2019) Table Europe Molecular Diagnostics Cancer Market Size by Type 2014-2019 (Million US$) Table Europe Molecular Diagnostics Cancer Market Share by Type 2014-2019 Table Europe Molecular Diagnostics Cancer Market Size by Application 2014-2019 (Million US$) Table Europe Molecular Diagnostics Cancer Market Share by Application 2014-2019 Figure China Molecular Diagnostics Cancer Market Size 2014-2019 (Million US$) Table China Key Players Molecular Diagnostics Cancer Revenue (2018-2019) (Million US$) Table China Key Players Molecular Diagnostics Cancer Market Share (2018-2019) Table China Molecular Diagnostics Cancer Market Size by Type 2014-2019 (Million US$) Table China Molecular Diagnostics Cancer Market Share by Type 2014-2019 Table China Molecular Diagnostics Cancer Market Size by Application 2014-2019 (Million US$) Table China Molecular Diagnostics Cancer Market Share by Application 2014-2019 Figure Japan Molecular Diagnostics Cancer Market Size 2014-2019 (Million US$) Table Japan Key Players Molecular Diagnostics Cancer Revenue (2018-2019) (Million US$) Table Japan Key Players Molecular Diagnostics Cancer Market Share (2018-2019) Table Japan Molecular Diagnostics Cancer Market Size by Type 2014-2019 (Million US$) Table Japan Molecular Diagnostics Cancer Market Share by Type 2014-2019 Table Japan Molecular Diagnostics Cancer Market Size by Application 2014-2019 (Million US$) Table Japan Molecular Diagnostics Cancer Market Share by Application 2014-2019 Figure Southeast Asia Molecular Diagnostics Cancer Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Molecular Diagnostics Cancer Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Molecular Diagnostics Cancer Market Share (2018-2019) Table Southeast Asia Molecular Diagnostics Cancer Market Size by Type 2014-2019 (Million US$) Table Southeast Asia Molecular Diagnostics Cancer Market Share by Type 2014-2019 Table Southeast Asia Molecular Diagnostics Cancer Market Size by Application 2014-2019 (Million US$) Table Southeast Asia Molecular Diagnostics Cancer Market Share by Application 2014-2019 Figure India Molecular Diagnostics Cancer Market Size 2014-2019 (Million US$) Table India Key Players Molecular Diagnostics Cancer Revenue (2018-2019) (Million US$) Table India Key Players Molecular Diagnostics Cancer Market Share (2018-2019) Table India Molecular Diagnostics Cancer Market Size by Type 2014-2019 (Million US$) Table India Molecular Diagnostics Cancer Market Share by Type 2014-2019 Table India Molecular Diagnostics Cancer Market Size by Application 2014-2019 (Million US$) Table India Molecular Diagnostics Cancer Market Share by Application 2014-2019 Figure Central & South America Molecular Diagnostics Cancer Market Size 2014-2019 (Million US$) Table Central & South America Key Players Molecular Diagnostics Cancer Revenue (2018-2019) (Million US$) Table Central & South America Key Players Molecular Diagnostics Cancer Market Share (2018-2019) Table Central & South America Molecular Diagnostics Cancer Market Size by Type 2014-2019 (Million US$) Table Central & South America Molecular Diagnostics Cancer Market Share by Type 2014-2019 Table Central & South America Molecular Diagnostics Cancer Market Size by Application 2014-2019 (Million US$) Table Central & South America Molecular Diagnostics Cancer Market Share by Application 2014-2019 Table Roche Company Details Table Roche Revenue in Molecular Diagnostics Cancer Business 2014-2019 (Million US$) Figure Roche Revenue Growth Rate in Molecular Diagnostics Cancer Business (2014-2019) Table Roche Recent Development Table Danaher Company Details Table Danaher Revenue in Molecular Diagnostics Cancer Business 2014-2019 (Million US$) Figure Danaher Revenue Growth Rate in Molecular Diagnostics Cancer Business (2014-2019) Table Danaher Recent Development Table Siemens Company Details Table Siemens Revenue in Molecular Diagnostics Cancer Business 2014-2019 (Million US$) Figure Siemens Revenue Growth Rate in Molecular Diagnostics Cancer Business (2014-2019) Table Siemens Recent Development Table Abbott Laboratories Company Details Table Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business 2014-2019 (Million US$) Figure Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Cancer Business (2014-2019) Table Abbott Laboratories Recent Development Table ICON Plc Company Details Table ICON Plc Revenue in Molecular Diagnostics Cancer Business 2014-2019 (Million US$) Figure ICON Plc Revenue Growth Rate in Molecular Diagnostics Cancer Business (2014-2019) Table ICON Plc Recent Development Table AstraZeneca Company Details Table AstraZeneca Revenue in Molecular Diagnostics Cancer Business 2014-2019 (Million US$) Figure AstraZeneca Revenue Growth Rate in Molecular Diagnostics Cancer Business (2014-2019) Table AstraZeneca Recent Development Table MDxHealth Company Details Table MDxHealth Revenue in Molecular Diagnostics Cancer Business 2014-2019 (Million US$) Figure MDxHealth Revenue Growth Rate in Molecular Diagnostics Cancer Business (2014-2019) Table MDxHealth Recent Development Table Invitae Company Details Table Invitae Revenue in Molecular Diagnostics Cancer Business 2014-2019 (Million US$) Figure Invitae Revenue Growth Rate in Molecular Diagnostics Cancer Business (2014-2019) Table Invitae Recent Development Table PlexBio Company Details Table PlexBio Revenue in Molecular Diagnostics Cancer Business 2014-2019 (Million US$) Figure PlexBio Revenue Growth Rate in Molecular Diagnostics Cancer Business (2014-2019) Table PlexBio Recent Development Table Thermo Fisher Scientific Company Details Table Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business 2014-2019 (Million US$) Figure Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Cancer Business (2014-2019) Table Thermo Fisher Scientific Recent Development Table Guardant Health Company Details Table Biocartis Company Details Table Bio-Techne Company Details Table Merck Company Details Table Foundation Medicine Company Details Table 10X Genomics Company Details Table Biodesix Company Details Table CytoTrack Company Details Table GenomOncology Company Details Table Luminex Company Details Table Global Molecular Diagnostics Cancer Market Size by Regions (Million US$) 2019-2025 Figure Global Molecular Diagnostics Cancer Market Size Share by Regions (2019-2025) Figure Global Molecular Diagnostics Cancer Market Size Share by Regions in 2025 Figure North America Molecular Diagnostics Cancer Market Size Forecast (2019-2025)(Million USD) Figure Europe Molecular Diagnostics Cancer Market Size Forecast (2019-2025)(Million USD) Figure China Molecular Diagnostics Cancer Market Size Forecast (2019-2025)(Million USD) Figure Japan Molecular Diagnostics Cancer Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Molecular Diagnostics Cancer Market Size Forecast (2019-2025)(Million USD) Figure India Molecular Diagnostics Cancer Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Molecular Diagnostics Cancer Market Size Forecast (2019-2025)(Million USD) Table Global Molecular Diagnostics Cancer Market Size by Product (2019-2025) (Million US$) Figure Global Molecular Diagnostics Cancer Market Size by Product (2019-2025) Figure Global Molecular Diagnostics Cancer Market Size by Product in 2025 Table Global Molecular Diagnostics Cancer Market Size by Application (2019-2025) (Million US$) Figure Global Molecular Diagnostics Cancer Market Size by Application (2019-2025) Figure Global Molecular Diagnostics Cancer Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Roche Danaher Siemens Abbott Laboratories ICON Plc AstraZeneca MDxHealth Invitae PlexBio Thermo Fisher Scientific Guardant Health Biocartis Bio-Techne Merck Foundation Medicine 10X Genomics Biodesix CytoTrack GenomOncology Luminex